Japan Tissue Engineering Co., Ltd. (7774.T) has a MoatMap StockRank of 29/100 based on Quality (34/100), Value (39/100), and Momentum (46/100) factor scores. The current signal is SELL. Japan Tissue Engineering is a Japanese healthcare company, likely specialized in a niche area. Specialized healthcare companies, especially smaller ones, often carry high R&D risk and do not present the broad, predictable quality compounder characteristics we seek. There is no clear asymmetric macro tailwind for this specific company.